| 0 (0%) | 01-19 18:53 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 2.19 | 1-year : | 2.56 |
| Resists | First : | 1.87 | Second : | 2.19 |
| Pivot price | 1.49  |
|||
| Supports | First : | 1.52 | Second : | 1.29 |
| MAs | MA(5) : | 1.64  |
MA(20) : | 1.47 |
| MA(100) : | 1.3 |
MA(250) : | 1.4 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 59.7 |
D(3) : | 61.3 |
| RSI | RSI(14): 59.9 |
|||
| 52-week | High : | 3.77 | Low : | 0.86 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ ALLO ] has closed below upper band by 26.8%. Bollinger Bands are 119.1% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 5 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 1.67 - 1.68 | 1.68 - 1.69 |
| Low: | 1.57 - 1.59 | 1.59 - 1.6 |
| Close: | 1.61 - 1.63 | 1.63 - 1.65 |
Mon, 19 Jan 2026
Andrew Allo Obituary (2026) - Edmond, OK - Crawford Family Funeral & Cremation Service - Edmond - Legacy | Obituary
Sat, 17 Jan 2026
Long-term CR Seen With Allo-CAR-NK Cell Therapy Plus Rituximab in Waldenstrom NHL - The American Journal of Managed Care
Fri, 09 Jan 2026
Are Medical Stocks Lagging Allogene Therapeutics (ALLO) This Year? - Yahoo Finance
Mon, 20 Oct 2025
Lincoln, Neb., Schools Partner With Allo Fiber for Student WiFi - GovTech
Fri, 17 Oct 2025
Students get free, city-wide WiFi under new ALLO partnership with Lincoln Public Schools - KLKN-TV
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 225 (M) |
| Shares Float | 155 (M) |
| Held by Insiders | 16.7 (%) |
| Held by Institutions | 63.2 (%) |
| Shares Short | 18,040 (K) |
| Shares Short P.Month | 18,700 (K) |
| EPS | -0.99 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.4 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -27.4 % |
| Return on Equity (ttm) | -54.5 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | -0.75 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -0.95 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -158 (M) |
| Levered Free Cash Flow | -84 (M) |
| PE Ratio | -1.67 |
| PEG Ratio | 0 |
| Price to Book value | 1.15 |
| Price to Sales | 0 |
| Price to Cash Flow | -2.32 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|